Swissmedic Approves QUVIVIQ to Treat Chronic Insomnia
QUVIVIQ will be the first dual orexin receptor antagonist available in Switzerland for the treatment of chronic insomnia.
Read More
Author: Lisa Spear
Circadian Perspectives: How Shorter Days Affect the Mood of Millions of Americans
A nutritional neuroscientist explains the connection between daylight saving time and winter depression.
Read More
What’s Really Going on When a Child is ‘Overtired’ – and How to Help Them go to Sleep
What we tend to call overtiredness happens when an emotional state, such as anxiety, distress or fear, blocks our ability to go to sleep even when we’re really tired. This is a survival response that helps us to stay awake when in danger, no matter how tired we are.
Read More
The Business of Clinical Trials Is Booming. Private Equity Has Taken Notice.
Private equity firms have moved aggressively into the healthcare industry’s more hidden niches: They are pouring billions into the business of clinical drug trials.
Read More
Lakeshore Approves Business Combination with ProSomnus
Lakeshore Acquisition I Corp today announced that its shareholders have approved all proposals related to the previously announced business combination with the oral appliance therapy company ProSomnus at a special meeting of shareholders held on Dec. 2, 2022.
Read More